SurModics (SRDX) Tops Q4 EPS by 15c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/7/2026
- S&P 500, Nasdaq reach record closing highs as focus pivots to earnings
- Oil prices fall nearly 2% as Middle East supply concerns ease
- U.S. 10-year yield climb revives dotcom-era parallels: UBS weighs in
- Goldman flags 2 key market risks if a climb in yields persists
- Shell CEO says Middle East oil flows reach 80% of prewar levels
- HubSpot to cut 7% of workforce in restructuring plan
- Emera and Canadian Utilities agree to merge in $72B all-share deal
- Caribou Biosciences to halt CAR-T programs, explore sale
- Stryker names Spencer Stiles as CEO, Lobo moves to chair
- Francis Halzen wins Nobel physics prize for Antarctic 'ghost particle' hunt
SurModics (SRDX) PT Lowered to $70 at Needham & Company
November 10, 2021 12:10 PM ESTNeedham & Company analyst Mike Matson lowered the price target on SurModics (NASDAQ: SRDX) to $70.00 (from $76.00) while maintaining a Buy rating.
The analyst commented, "SRDX's F4Q21 revenue and EPS beat consensus. Initial FY22 revenue and EPS guidance was well below consensus... More



